Skip to content

Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions

COTEPS: Monitoring of Incidence of Mental Discomfort in the Population of Pregnant Women in the Third Trimester During the Serious COVID-19 Pandemic Conditions

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04898192
Acronym
COTEPS
Enrollment
1500
Registered
2021-05-24
Start date
2021-04-01
Completion date
2022-08-01
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant Woman

Keywords

mental state, pregnancy, COVID

Brief summary

This study is aimed to detect severe fear of delivery and its association with the incidence of obsessive-compulsive disorder and symptoms of depression and anxiety in the population of pregnant women in the third trimester during the serious COVID-19 pandemic situation in Slovakia. Data will be acquired from three departments of gynaecology and obstetrics of University Hospital Bratislava. The majority of pregnancies from the region are managed in this hospital; the total number of deliveries in 2020 achieved 7,835

Detailed description

The pregnancy is a risk factor for the first manifestation of several mental disorders. Current serious pandemic situation and a constant risk of COVID-19 infection negatively affects the mental state of the population, risk groups of pregnant women in particular. The aim of this project is to discover the incidence of symptoms of depression, anxiety and obsessive-compulsive disorder in association with the fear of delivery in current COVID-19 pandemic conditions in Slovakia. We also decided to add a short tool for detection of domestic violence among other scales to detect the incidence among Slovak pregnant population. All pregnant women in their third trimester who visit the prenatal clinic for their routine weekly check-up will be asked to participate in the study. The questionnaire which comprises of validated mental scales will be handed out to the patients waiting for their examination. After collection of filled questionnaires, those will be later paired with patients' medical documentation and statistically evaluated. The questionnaires will be collected during the period of 1.4.2021-31.3.2022 and statistical analysis will be conducted in the period of 1.4.2022-1.8.2022. It is expected that approximately 1,500 women will be included into the study. All three departments of gynaecology and obstetrics of the University Hospital Bratislava will participate at the study. In total, approximately 7,800 deliveries a year are managed in the University Hospital Bratislava. Following questionnaires are planned to be used in the study: * Wijma Delivery Expectancy/Experience Questionnaire - aimed at fear of delivery * PASS (Perinatal Anxiety Screening Scale) - aimed at anxiety in women before and after delivery * PHQ-9-SK (Patient Health Questionnaire) - aimed at depressive disorder * HITS Domestic Violence Screening Tool - aimed at domestic violence * DOK (The Obsessive-Compulsive Inventory) - aimed at obsessive and compulsive symptoms * GAD-7 (General Anxiety Disorder-7) - aimed at general anxiety disorder * EPDS (Edinburgh Postnatal Depression Scale) - aimed at symptoms of postpartal depression

Interventions

OTHERquestionnaire

questionnaire - the complex of 6 questionnaires aimed to recognize the fear of delivery, perinatal anxiety, depressive disorder, obsessive-compulsive disorder, general anxiety disorder, postpartal depression and domestic violence.

Sponsors

Comenius University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnancy after 34th week * Vital fetus

Exclusion criteria

* Unwilling to participate * Age less than 18 years * Foetus mortus or perinatal death of the newborn * Low knowledge of Slovak language * Serious pathology in the pregnancy (e.g. placenta praevia, known congenital disorders)

Design outcomes

Primary

MeasureTime frameDescription
prevalence and risk factors9 monthsprevalence and risk factors of depression, anxiety and obsessive-compulsive disorder in the population of pregnant women in association with COVID-19 pandemic situation.

Countries

Slovakia

Contacts

Primary ContactPeter Musil, PhD.
peter.musil@fmed.uniba.sk+421903836788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026